Obstructive sleep apnoea, a condition where breathing repeatedly stops and starts during sleep, isn’t just a personal health concern—it’s a significant drag on the economies of the United States and the United Kingdom. New research reveals the condition costs these nations a staggering £137 billion ($185 billion) annually, primarily through lost workdays and diminished productivity. The findings underscore the urgent demand for increased awareness, earlier diagnosis, and more effective treatment options for this often-undiagnosed condition.
Characterized by loud snoring, gasping for air during sleep, and excessive daytime fatigue, obstructive sleep apnoea affects an estimated 1 billion people worldwide, including around 8 million in the UK. Despite its prevalence, a concerning 85% of cases remain undiagnosed. Beyond the immediate impact on quality of life, untreated sleep apnoea is linked to serious health risks, including increased chances of heart attack and stroke, making it a critical public health issue.
The study, led by researchers at University College London and published in the journal Thorax, surveyed over 4,000 adults in the UK and US. Roughly one in five respondents reported experiencing the core symptoms of sleep apnoea: breathing pauses during sleep on three or more nights, coupled with excessive daytime sleepiness. Researchers then extrapolated the economic impact of this widespread condition, calculating an annual loss of $180 billion (£133 billion) for the US economy and £4.2 billion for the UK.
The Hidden Costs of Lost Sleep
The economic burden identified in the study likely represents a conservative estimate. The researchers noted that their analysis didn’t fully account for increased medical expenses associated with sleep apnoea or the costs stemming from road traffic and workplace accidents potentially linked to the condition. The impact extends beyond direct financial losses; untreated sleep apnoea can contribute to presenteeism – being at work but functioning at a reduced capacity – and increased absenteeism, further hindering economic output.
The core issue, experts say, is that sleep apnoea often goes unnoticed. The NHS explains that symptoms like loud snoring, making gasping or choking noises during sleep, and waking up frequently are key indicators. However, these symptoms are often dismissed or attributed to other causes. A healthcare provider can assess symptoms and, if necessary, refer patients for sleep studies to measure breathing patterns and determine the severity of the condition, using an AHI (Apnoea-Hypopnoea Index) score.
Treatment Challenges and Workplace Concerns
While continuous positive airway pressure (CPAP) therapy remains the gold standard for treating obstructive sleep apnoea, adherence rates are surprisingly low. Nearly two-thirds of patients discontinue CPAP therapy, highlighting the challenges of long-term compliance. Alternative treatments, such as weight loss medications, oral appliances to maintain an open airway, and hypoglossal nerve stimulation implants, are available, but aren’t suitable for all patients. Weight loss drugs are showing promise, but are not a universal solution.
The study’s call for workplace screening raises complex considerations. While early detection could lead to significant economic benefits, concerns exist about potential discrimination. Adrian Jones, national officer at the trade union Unite, which represents many transport workers, emphasized the need for safeguards. “Professional drivers often hide issues of sleep apnoea out of fear of losing their jobs,” he said. “Before introducing screening, employers must be fully educated that sleep apnoea can be effectively managed. Workers must have the confidence that they will be supported, not dismissed, if a problem is identified.”
Looking Ahead: Screening and Support
The authors of the Thorax study advocate for policymakers to prioritize the development of effective screening strategies and public health campaigns to raise awareness about obstructive sleep apnoea. Early identification, coupled with proactive follow-up care, could unlock substantial savings and improve the health and well-being of millions. The economic implications are clear: addressing this widespread, yet often overlooked, condition is not just a matter of public health, but as well a sound economic investment.
The potential for new, low-cost technologies and screening algorithms offers a glimmer of hope for improving diagnosis rates. However, successful implementation hinges on addressing the barriers to treatment adherence and ensuring that workers feel safe seeking help without fear of repercussions. Further research is needed to refine screening protocols and develop more accessible and effective treatment options.
Disclaimer: This article provides information for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
What are your thoughts on workplace screening for sleep apnoea? Share your comments below, and please share this article with anyone who might benefit from this information.
Worth a look
